Why The Supreme Court’s Skinny-Label Ruling Matters

 
• By Dave Wallace
  
The US Supreme Court’s decision could create a “bright line rule” for skinny-label generics, Landmon said. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Generics

More from United States